Lara Sullivan, MD,

Bio:

Dr. Lara S. Sullivan is the President, Chief Executive Officer and Chief Medical Officer of Pyxis Oncology. Lara joined Pyxis Oncology shortly after its founding and has led the company from Series A through its transition to a public company, raising over $350M to advance the pipeline. Prior to joining Pyxis Oncology in 2019, Lara was Founding President of SpringWorks Therapeutics (NASDAQ: SWTX), a clinical stage biopharmaceutical company she conceived of, founded, and spun out from Pfizer. As a biotech entrepreneur and advisor, Lara has leveraged her expertise in asset evaluation, portfolio management, and start-up financing to raise nearly $500 million of capital from seed stage through IPO. While at Pfizer, Lara held a variety of executive roles including Vice President, Pfizer Medical and Vice President, Worldwide Research & Development, where she led strategy, competitive intelligence and portfolio operations for the company’s early-stage R&D pipeline. Earlier in her career, Lara held a variety of roles in management consulting, private equity, and investment banking. Lara holds an M.D. from the University of Pennsylvania School of Medicine, an M.B.A. from The Wharton School at the University of Pennsylvania, and a B.A. in Comparative Literature from Cornell University.